Medical and health researchers

Michael Bretthauer

Michael Bretthauer is a Norwegian gastroenterologist and professor of medicine at the University of Oslo, lead principal investigator of the NordICC trial, the first randomized trial of colonoscopy screening.

Michael C. Heinrich

Michael C. Heinrich is an American medical oncologist and professor at the OHSU Knight Cancer Institute, known for identifying PDGFRA mutations in gastrointestinal stromal tumor and leading trials of tyrosine kinase inhibitors.

Michael C. Kew

Michael C. Kew (1939–2021) was a South African hepatologist at the University of the Witwatersrand who helped establish the link between hepatitis B and liver cancer.

Michael C. Lu

Michael C. Lu is an American physician and maternal and child health researcher who serves as dean of the UC Berkeley School of Public Health.

Michael C. Sanguinetti

Michael C. Sanguinetti is a cardiac electrophysiologist and professor emeritus at the University of Utah whose work identified the hERG channel underlying long QT syndrome and drug safety testing.

Michael Camilleri

Michael Camilleri, born 1952, is a Maltese-born gastroenterologist and professor at Mayo Clinic in Rochester, Minnesota, known for research on irritable bowel syndrome, chronic constipation, and gastroparesis.

Michael Charlton (hepatologist)

Michael Charlton is a British-trained hepatologist who led the trials establishing curative hepatitis C treatment and directed the University of Chicago Transplant Institute from 2017 to 2024.

Michael Chopp

Michael Chopp is an American neuroscientist who has led stroke research at Henry Ford Health since 1983, showing that transplanted bone marrow stromal cells stimulate the injured brain's own repair.

Michael D. Dake

Michael D. Dake is an American interventional radiologist who implanted the first thoracic aortic stent-graft in the United States at Stanford in 1992, and later led the University of Arizona Health Sciences.

Michael D. Ezekowitz

Michael D. Ezekowitz is a South African-trained American cardiologist whose 1992 warfarin trial established stroke prevention in atrial fibrillation and who co-led the RE-LY dabigatran trial.

Michael D. Gershon

Michael D. Gershon, born 1938, is an American physician-scientist at Columbia University called the "father of neurogastroenterology" for establishing serotonin as a gut signaling molecule.

Michael D. Greicius

Michael D. Greicius, also known as Michael Greicius, is a Stanford neurologist who studies Alzheimer's disease through brain imaging and genetics, and founded the Stanford Center for Memory Disorders.

Michael D. Jensen

Michael D. Jensen is an American endocrinologist and obesity researcher at Mayo Clinic, known for his 1999 Science study on nonexercise activity and fat gain.

Michael D. Levitt

Michael D. Levitt was an American gastroenterologist at the Minneapolis VA and University of Minnesota, known for measuring intestinal gas and developing the hydrogen breath test.

Michael D. Taylor

Michael D. Taylor is a Canadian pediatric neurosurgeon who spent 18 years at Toronto's SickKids before moving in 2023 to Baylor College of Medicine, known for showing medulloblastoma is four distinct diseases.

Michael David (molecular biologist)

Michael David is an Austrian-trained molecular biologist and Emeritus Professor of Molecular Biology at UC San Diego whose research centers on interferons and the JAK/STAT pathway.

Michael Davis (biomedical engineer)

Michael E. Davis is an American biomedical engineer, professor at Georgia Tech and Emory, who directs the HeRO Center and works on cardiac regeneration with biomaterials and stem cells.

Michael Dean (molecular biologist)

Michael Dean is an American molecular biologist and human geneticist at the National Cancer Institute known for work on the cystic fibrosis gene and HIV resistance.

Michael Detmar

Michael Detmar (born 1957) is a German dermatologist, professor of pharmacogenomics at ETH Zurich since 2004, known for establishing tumor lymphangiogenesis as a mechanism of cancer spread.

Michael Doherty (rheumatologist)

Michael Doherty is a British rheumatologist and Emeritus Professor at the University of Nottingham, known for landmark osteoarthritis papers and a 2018 Lancet trial of nurse-led gout care.

Michael E. Farkouh

Michael E. Farkouh is a cardiologist and clinical trialist who directs research at Cedars-Sinai in Los Angeles and led the FREEDOM trial showing bypass surgery beats stenting for diabetic patients with multivessel disease.

Michael E. Matheny

Michael E. Matheny is an American physician and biomedical informatics researcher at Vanderbilt University Medical Center, elected to the National Academy of Medicine in 2025.

Michael E. Mendelsohn

Michael E. Mendelsohn, also published as Michael Mendelsohn, is an American physician-scientist in vascular biology and cardiology known for research on estrogen and nitric oxide signaling in blood vessels.

Michael E. Phelps

Michael E. Phelps, born in 1939, is an American scientist credited with inventing the PET scanner in 1973, developing four generations of scanners, and founding CTI Molecular Imaging.

Michael E. Wechsler

Michael E. Wechsler is an American pulmonologist who directs the Cohen Family Asthma Institute and researches severe asthma and EGPA at National Jewish Health in Denver.

Michael E. Weinblatt

Michael E. Weinblatt, also known as Michael Weinblatt, is an American rheumatologist at Brigham and Women's Hospital and Harvard Medical School known for rheumatoid arthritis drug trials.

Michael Eddleston

Michael Eddleston is a British clinical toxicologist and professor at the University of Edinburgh whose research on pesticide self-poisoning in Sri Lanka led to pesticide bans and WHO recommendations.

Michael F. Chiang

Michael F. Chiang is an American pediatric ophthalmologist and clinical informatician who has directed the National Eye Institute since 2020 and is known for telemedicine and deep learning diagnosis of retinopathy of prematurity.

Michael F. Fleming

Michael F. Fleming is an American physician-scientist in family medicine and addiction medicine, known for research on screening and brief intervention for unhealthy alcohol and opioid use in primary care.